362 related articles for article (PubMed ID: 15505058)
21. Levels and activation of matrix metalloproteinases in aqueous humor are elevated in uveitis-related secondary glaucoma.
Määttä M; Tervahartiala T; Vesti E; Airaksinen J; Sorsa T
J Glaucoma; 2006 Jun; 15(3):229-37. PubMed ID: 16778646
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of matrix metalloproteinases and their tissue inhibitors at the advancing pterygium head.
Di Girolamo N; Wakefield D; Coroneo MT
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4142-9. PubMed ID: 11095607
[TBL] [Abstract][Full Text] [Related]
23. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinase, collagens, and Ki67 antigen in pleural malignant mesothelioma: an immunohistochemical and electron microscopic study.
Hirano H; Tsuji M; Kizaki T; Sashikata T; Yoshi Y; Okada Y; Mori H
Med Electron Microsc; 2002 Mar; 35(1):16-23. PubMed ID: 12111403
[TBL] [Abstract][Full Text] [Related]
24. Expression and prognostic significance of matrix metalloproteinases and their tissue inhibitors in primary neuroendocrine carcinoma of the skin.
Massi D; Franchi A; Ketabchi S; Paglierani M; Pimpinelli N; Santucci M
Hum Pathol; 2003 Jan; 34(1):80-8. PubMed ID: 12605370
[TBL] [Abstract][Full Text] [Related]
25. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors.
Fondard O; Detaint D; Iung B; Choqueux C; Adle-Biassette H; Jarraya M; Hvass U; Couetil JP; Henin D; Michel JB; Vahanian A; Jacob MP
Eur Heart J; 2005 Jul; 26(13):1333-41. PubMed ID: 15827062
[TBL] [Abstract][Full Text] [Related]
26. [Effects of matrix metalloproteinase-3, osteopontin, and tissue inhibitor of metalloproteinase-1 in the formation of cataract].
Tan Q; Jiang J; Luo DQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):737-41. PubMed ID: 17062942
[TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinases as mediators of tissue injury in different forms of cutaneous lupus erythematosus.
Järvinen TM; Kanninen P; Jeskanen L; Koskenmies S; Panelius J; Hasan T; Ranki A; Saarialho-Kere U
Br J Dermatol; 2007 Nov; 157(5):970-80. PubMed ID: 17854363
[TBL] [Abstract][Full Text] [Related]
28. [Immunohistochemical localization of matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in tuberculous pleuritis].
Hoheisel G; Sack U; Hui DS; Lai F; Chan KS; Choi CH; Schauer J; Tannapfel A
Pneumologie; 2004 May; 58(5):305-8. PubMed ID: 15162254
[TBL] [Abstract][Full Text] [Related]
29. Purified human chondroitin-4-sulfate reduced MMP/TIMP imbalance induced by iron plus ascorbate in human fibroblast cultures.
Campo GM; Avenoso A; Campo S; D'Ascola A; Ferlazzo AM; Samà D; Calatroni A
Cell Biol Int; 2006 Jan; 30(1):21-30. PubMed ID: 16275145
[TBL] [Abstract][Full Text] [Related]
30. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
[TBL] [Abstract][Full Text] [Related]
31. Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma.
Naka T; Kuester D; Boltze C; Schulz TO; Samii A; Herold C; Ostertag H; Roessner A
Hum Pathol; 2008 Feb; 39(2):217-23. PubMed ID: 17949787
[TBL] [Abstract][Full Text] [Related]
32. Matrix metalloproteinase-9 activity in human lens epithelial cells of cortical, posterior subcapsular, and nuclear cataracts.
Alapure BV; Praveen MR; Gajjar D; Vasavada AR; Rajkumar S; Johar K
J Cataract Refract Surg; 2008 Dec; 34(12):2063-7. PubMed ID: 19027560
[TBL] [Abstract][Full Text] [Related]
33. Involvement of protein kinase C in TNFalpha regulation of trabecular matrix metalloproteinases and TIMPs.
Alexander JP; Acott TS
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2831-8. PubMed ID: 11687525
[TBL] [Abstract][Full Text] [Related]
34. Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves.
Dreger SA; Taylor PM; Allen SP; Yacoub MH
J Heart Valve Dis; 2002 Nov; 11(6):875-80; discussion 880. PubMed ID: 12479292
[TBL] [Abstract][Full Text] [Related]
35. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
Matsunaga Y; Koda M; Murawaki Y
Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
[TBL] [Abstract][Full Text] [Related]
36. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
[TBL] [Abstract][Full Text] [Related]
37. Prevention of UV-induced damage to the anterior segment using class I UV-absorbing hydrogel contact lenses.
Chandler HL; Reuter KS; Sinnott LT; Nichols JJ
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):172-8. PubMed ID: 19710408
[TBL] [Abstract][Full Text] [Related]
38. Upregulated expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in BALB/c mouse brain challenged with Japanese encephalitis virus.
Shukla V; Kumar Shakya A; Dhole TN; Misra UK
Neuroimmunomodulation; 2012; 19(4):241-54. PubMed ID: 22441541
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of matrix metalloproteinases and their inhibitors in non-small cell lung cancer.
Thomas P; Khokha R; Shepherd FA; Feld R; Tsao MS
J Pathol; 2000 Feb; 190(2):150-6. PubMed ID: 10657012
[TBL] [Abstract][Full Text] [Related]
40. The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells.
Fujisaki K; Tanabe N; Suzuki N; Mitsui N; Oka H; Ito K; Maeno M
Life Sci; 2006 Mar; 78(17):1975-82. PubMed ID: 16313928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
